Lamisil is an
anti-fungal drug manufactured by Novartis Pharmaceuticals. The FDA issued a warning to
doctors, patients, and
pharmacists regarding the tendency to confuse Lamisil with the epilepsy drug
Lamictal. People with anti-fungal infections who mistakenly take Lamictal may aggravate their rashes. Additionally, if confusion leads an epileptic to take Lamisil rather than Lamictal, the epileptic's
seizures may not be controlled properly.
Recently, the FDA issued a report warning doctors of the danger associated with treating fungal nail and skin infections with Lamisil if the patient also suffers from liver problems. The drug was found to cause adverse
liver reactions in over a dozen people, killing several. The safety warning only applies to Lamisil tablets, not the cream version of the medication. You should see your doctor if you have concerns about the safety of Lamisil.
If you have experienced adverse side effects associated with Lamisil it may be important to
contact an attorney who can help you protect your legal rights. Please keep in mind that there may be
time limits within which you must commence suit.
See Also
- Anti-fungal Drugs: Overview
- Liver Problems
- Lamisil: Frequently Asked Questions